Anthracene

Anthracene

SCHEMBL7565962

Nc1ccccc1C(=O)O.c1ccc2cc3ccccc3cc2c1

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.68
MAPT P10636 4/20 0.53
GAA P10253 2/20 0.53
MMP2 P08253 1/20 0.53
ALDH1A1 P00352 8/20 0.52
ALOX15 P16050 1/20 0.52
KDM4E B2RXH2 7/20 0.50
KMT2A Q03164 3/20 0.50
GFER P55789 2/20 0.50
NR4A1 P22736 1/20 0.50
NR4A2 P43354 1/20 0.50
NR4A3 Q92570 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
MEN1 O00255 2/20 0.48
POLB P06746 2/20 0.48
USP2 O75604 1/20 0.48
THRB P10828 1/20 0.48
PKM P14618 1/20 0.48
APEX1 P27695 1/20 0.48
RECQL P46063 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anthranilic Acid SCHEMBL362171 0.89 ALDH1A1 (0.65) IDO1MAPTGAAMMP2ALDH1A1
Anthranilic Acid SCHEMBL2961107 0.89 ALDH1A1 (0.65) IDO1MAPTGAAMMP2ALDH1A1
Anthranilic Acid SCHEMBL29365173 0.89 ALDH1A1 (0.65) IDO1MAPTGAAMMP2ALDH1A1
Anthranilic Acid SCHEMBL3110791 0.89 ALDH1A1 (0.65) IDO1MAPTGAAMMP2ALDH1A1
Anthranilic Acid SCHEMBL2953168 0.89 ALDH1A1 (0.65) IDO1MAPTGAAMMP2ALDH1A1
Anthranilic Acid SCHEMBL29802554 0.89 ALDH1A1 (0.65) IDO1MAPTGAAMMP2ALDH1A1
Anthranilic Acid SCHEMBL675 0.89 ALDH1A1 (0.65) IDO1MAPTGAAMMP2ALDH1A1
Naphthylamine SCHEMBL28916448 0.87 ALDH1A1 (0.59) IDO1MAPTGAAMMP2ALDH1A1
Anthranilic Acid SCHEMBL1282042 0.87 ALDH1A1 (0.62) IDO1MAPTGAAMMP2ALDH1A1
Anthranilic Acid SCHEMBL10405801 0.87 ALDH1A1 (0.62) IDO1MAPTGAAMMP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020193369-A1 Antifungal compounds and uses therefor PROTEZ PHARMACEUTICALS INC. 2002-12-19 US disclosed
WO-2002036203-A2 AZOLE CONTAINING COMPOSITIONS WITH ENHANCED ANTIFUNGAL ACTIVITY INFLUX, INC. (US) 2002-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193369-A1 Antifungal compounds and uses therefor CYP51A1, ERG28, TPP1 IDO1 178/4885MAPT 1801/4885GAA 1054/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.